- Origin: Missouri
- Grant awarded in: 2013
What is MagBiosense?
MagBiosense is a biotechnology platform developed to commercialize a novel cardiac biomarker diagnostic technology that brings lab-quality, high-sensitivity detection to the point-of-care. The device will change how heart attacks are diagnosed in the Emergency Department by providing high-sensitivity detection of cardiac troponin I.
Amos Danielli is the Founder of MagBiosense, a 2013 Arch Grants recipient.
Amos earned his degree in Electrical Engineering from Tel Aviv University in 1997, and holds both a Masters and PhD in Physical-Electronics from Tel Aviv University. Amos worked with Washington University in St. Louis and Helioris Solar Systems before joining MagBiosense.
Orr Hadass is a Consultant with MagBiosense, a 2013 Arch Grants recipient.
Orr earned his degree in Biomedical Engineering from Saint Louis University in 2009, and holds a Masters in Pathology & Neuroscience from University of Missouri-Columbia. Before joining MagBiosense, Orr worked with Kypha, Inc. and bioMerieux.
Jasenka Verbarg is the Senior Scientist at MagBiosense, a 2013 Arch Grants recipient.
Jasenka earned her degree in Biomedical Engineering from Saint Louis University in 2006, and holds a PhD in Biological Engineering from University of Missouri-Columbia. Before joining MagBiosense, Jasenka worked with the Naval Research Laboratory and the University of Missouri.